Danish Novo Nordisk - world-leading manufacturer of insulin and weight loss preparations - has agreed to buy a pharmaceutical factory in Bohumil, the Czech Republic, for 200 million dollars (equivalent to 2.2 billion kronor).
The seller is vaccine manufacturer Novavax.
The deal is expected to be completed before the end of the year, according to a press release.
